4//SEC Filing
CATABASIS PHARMACEUTICALS INC 4
Accession 0001179110-17-002160
$ATXSCIK 0001454789operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:07 PM ET
Size
5.5 KB
Accession
0001179110-17-002160
Insider Transaction Report
Form 4
Cunnane Deirdre A.
SVP, General Counsel
Transactions
- Award
Stock Option (right to buy)
2017-02-09+100,000→ 100,000 totalExercise: $1.24Exp: 2027-02-08→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 9, 2017 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 9, 2017 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001454789
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:07 PM ET
- Size
- 5.5 KB